From: Pharmacogenomics of hepatitis C infections: personalizing therapy
Location | SNP | Haplotype | |||||
---|---|---|---|---|---|---|---|
 |  | 1a | 2b | 3 | 4a | 5 | 6 |
5' | rs7248668 | G | A | G | G | G | G |
5' | rs8099917c | T | G | T | T | T | T |
5' | rs8109886 | C | A | A | A | A | A |
5', CpG | rs4803221 | C | G | C | C | C | G |
5', CpG | rs12979860c | C | T | T | C | T | T |
Exon 2 | rs8103142 | T | C | C | T | C | C |
Intron 2 | rs11881222 | A | G | G | A | A | G |
3' | rs688187 | G | A | A | G | A | A |
3' | rs8105790 | T | C | C | T | T | C |
3' | rs12982533 | T | C | C | T | T | C |
3' | rs12980275 | A | G | G | A | A | G |
OR (95% CI) | 0.70 (0.57-0.85) | 2.20 (1.72-2.80) | 1.04 (0.75-1.43) | 0.60 (0.43-0.83) | 0.79 (0.39-1.60) | 1.49 (0.62-3.56) | |
%CEU (CHC) | 43.2 | 23.8 | 10.3 | 9.8 | 1.9 | 1.4 |